{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T12:23:12Z","timestamp":1758630192698},"reference-count":61,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","progcardvascdis.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.pcad.2017.12.002","type":"journal-article","created":{"date-parts":[[2017,12,28]],"date-time":"2017-12-28T18:10:14Z","timestamp":1514484614000},"page":"537-541","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Quantifying Time in Atrial Fibrillation and the Need for Anticoagulation"],"prefix":"10.1016","volume":"60","author":[{"given":"Kazuo","family":"Miyazawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Pastori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2017.12.002_bb0005","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2017.12.002_bb0010","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jacc.2006.10.062","article-title":"Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study","volume":"49","author":"Miyasaka","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2017.12.002_bb0015","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.pcad.2017.12.002_bb0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10840-008-9318-y","article-title":"Quality of life in older people with atrial fibrillation","volume":"25","author":"Lane","year":"2009","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.pcad.2017.12.002_bb0025","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0002-9343(02)01236-6","article-title":"A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew\/Paisley study","volume":"113","author":"Stewart","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.pcad.2017.12.002_bb0030","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/01.STR.27.10.1760","article-title":"Stroke severity in atrial fibrillation. The Framingham study","volume":"27","author":"Lin","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.pcad.2017.12.002_bb0035","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/europace\/eus305","article-title":"2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation--developed with the special contribution of the European heart rhythm association","volume":"14","author":"Camm","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.pcad.2017.12.002_bb0040","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pcad.2017.12.002_bb0045","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2017.12.002_bb0050","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2017.12.002_bb0055","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2017.12.002_bb0060","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2017.12.002_bb0065","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1253\/circj.CJ-12-0105","article-title":"Distribution of first-detected atrial fibrillation patients without structural heart diseases in symptom classifications","volume":"76","author":"Senoo","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.pcad.2017.12.002_bb0070","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jacc.2009.11.040","article-title":"Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis","volume":"55","author":"de Vos","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2017.12.002_bb0075","doi-asserted-by":"crossref","first-page":"281a","DOI":"10.1093\/eurheartj\/ehu307","article-title":"Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES","volume":"36","author":"Vanassche","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2017.12.002_bb0080","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/eurheartj\/ehu359","article-title":"Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF trial","volume":"36","author":"Steinberg","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2017.12.002_bb0085","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/eurheartj\/ehw007","article-title":"The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis","volume":"37","author":"Ganesan","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2017.12.002_bb0090","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1093\/eurheartj\/ehm308","article-title":"Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm cohort-study of atrial fibrillation (SCAF)","volume":"28","author":"Friberg","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2017.12.002_bb0095","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1056\/NEJMoa1311376","article-title":"Atrial fibrillation in patients with cryptogenic stroke","volume":"370","author":"Gladstone","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2017.12.002_bb0100","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2017.12.002_bb0105","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/STROKEAHA.115.009930","article-title":"New appraisal of atrial fibrillation burden and stroke prevention","volume":"47","author":"Passman","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.pcad.2017.12.002_bb0110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1023\/B:JICE.0000026917.82516.eb","article-title":"Preventricular far-field sensing in the atrial channel of dual chamber pacemakers\u2014an occasional cause of inappropriate mode switch","volume":"10","author":"Kolb","year":"2004","journal-title":"J Interv Card Electrophysiol"},{"key":"10.1016\/j.pcad.2017.12.002_bb0115","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1540-8167.2006.00545.x","article-title":"Management of far-field R wave sensing for the avoidance of inappropriate mode switch in dual chamber pacemakers: results of the FFS-test study","volume":"17","author":"Kolb","year":"2006","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.pcad.2017.12.002_bb0120","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1540-8167.2002.00542.x","article-title":"Atrial fibrillation after DDDR pacemaker implantation","volume":"13","author":"Gillis","year":"2002","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.pcad.2017.12.002_bb0125","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1161\/01.CIR.0000057981.70380.45","article-title":"Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the atrial diagnostics ancillary study of the MOde selection trial (MOST)","volume":"107","author":"Glotzer","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2017.12.002_bb0130","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2005.07.044","article-title":"Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers","volume":"46","author":"Capucci","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2017.12.002_bb0135","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/CIRCEP.109.849638","article-title":"The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study","volume":"2","author":"Glotzer","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.pcad.2017.12.002_bb0140","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/europace\/eur293","article-title":"Detection of atrial high-rate events by continuous home monitoring: clinical significance in the heart failure-cardiac resynchronization therapy population","volume":"14","author":"Shanmugam","year":"2012","journal-title":"Europace"},{"key":"10.1016\/j.pcad.2017.12.002_bb0145","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2017.12.002_bb0150","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.hrthm.2014.08.019","article-title":"Newly detected atrial high rate episodes predict long-term mortality outcomes in patients with permanent pacemakers","volume":"11","author":"Gonzalez","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pcad.2017.12.002_bb0155","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/europace\/euu267","article-title":"Silent ischaemic brain lesions related to atrial high rate episodes in patients with cardiac implantable electronic devices","volume":"17","author":"Benezet-Mazuecos","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.pcad.2017.12.002_bb0160","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/eurheartj\/ehv115","article-title":"Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices","volume":"36","author":"Martin","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2017.12.002_bb0165","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1093\/eurheartj\/ehp298","article-title":"Guidelines for the diagnosis and management of syncope (version 2009)","volume":"30","author":"Task Force for the D","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2017.12.002_bb0170","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1212\/WNL.0b013e31828f1828","article-title":"Incidence of atrial fibrillation detected by implantable loop recorders in unexplained stroke","volume":"80","author":"Cotter","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.pcad.2017.12.002_bb0175","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1161\/STROKEAHA.111.676189","article-title":"Occult atrial fibrillation in cryptogenic stroke: detection by 7-day electrocardiogram versus implantable cardiac monitors","volume":"44","author":"Ritter","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.pcad.2017.12.002_bb0180","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/STROKEAHA.113.001340","article-title":"Insertable cardiac event recorder in detection of atrial fibrillation after cryptogenic stroke: an audit report","volume":"44","author":"Etgen","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.pcad.2017.12.002_bb0185","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/ene.12400","article-title":"Paroxysmal atrial fibrillation occurs often in cryptogenic ischaemic stroke. Final results from the SURPRISE study","volume":"21","author":"Christensen","year":"2014","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.pcad.2017.12.002_bb0190","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","article-title":"Cryptogenic stroke and underlying atrial fibrillation","volume":"370","author":"Sanna","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2017.12.002_bb0195","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/ene.12843","article-title":"Insertable cardiac monitors after cryptogenic stroke\u2014a risk factor based approach to enhance the detection rate for paroxysmal atrial fibrillation","volume":"23","author":"Poli","year":"2016","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.pcad.2017.12.002_bb0200","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/clc.22387","article-title":"Feasibility of extended ambulatory electrocardiogram monitoring to identify silent atrial fibrillation in high-risk patients: the Screening Study for Undiagnosed Atrial Fibrillation (STUDY-AF)","volume":"38","author":"Turakhia","year":"2015","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.pcad.2017.12.002_bb0205","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/14017430802593435","article-title":"Short-term ECG for out of hospital detection of silent atrial fibrillation episodes","volume":"43","author":"Doliwa","year":"2009","journal-title":"Scand Cardiovasc J"},{"key":"10.1016\/j.pcad.2017.12.002_bb0210","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/europace\/eus366","article-title":"Prevalence of unknown atrial fibrillation in patients with risk factors","volume":"15","author":"Samol","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.pcad.2017.12.002_bb0215","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.amjcard.2014.07.016","article-title":"Comparison of the microlife blood pressure monitor with the Omron blood pressure monitor for detecting atrial fibrillation","volume":"114","author":"Wiesel","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.pcad.2017.12.002_bb0220","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12325-011-0087-0","article-title":"Comparison of microlife BP A200 plus and Omron M6 blood pressure monitors to detect atrial fibrillation in hypertensive patients","volume":"29","author":"Marazzi","year":"2012","journal-title":"Adv Ther"},{"key":"10.1016\/j.pcad.2017.12.002_bb0225","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004565","article-title":"Triage tests for identifying atrial fibrillation in primary care: a diagnostic accuracy study comparing single-lead ECG and modified BP monitors","volume":"4","author":"Kearley","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.pcad.2017.12.002_bb0230","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3399\/bjgp11X548956","article-title":"Screening for atrial fibrillation: sensitivity and specificity of a new methodology","volume":"61","author":"Lewis","year":"2011","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.pcad.2017.12.002_bb0235","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.hrthm.2012.12.001","article-title":"A novel application for the detection of an irregular pulse using an iPhone 4S in patients with atrial fibrillation","volume":"10","author":"McManus","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pcad.2017.12.002_bb0240","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.hrthm.2016.03.003","article-title":"Typical, atypical, and asymptomatic presentations of new-onset atrial fibrillation in the community: characteristics and prognostic implications","volume":"13","author":"Siontis","year":"2016","journal-title":"Heart Rhythm"},{"issue":"17","key":"10.1016\/j.pcad.2017.12.002_bb0245","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/eurheartj\/ehx042","article-title":"Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT","volume":"38","author":"Van Gelder","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pcad.2017.12.002_bb0250","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1160\/TH16-11-0876","article-title":"Stroke prevention in atrial fibrillation: past, present and future. Comparing the guidelines and practical decision-making","volume":"117","author":"Lip","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pcad.2017.12.002_bb0255","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ijcard.2015.08.054","article-title":"Inadequate anticoagulation by vitamin K antagonists is associated with major adverse cardiovascular events in patients with atrial fibrillation","volume":"201","author":"Pastori","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.pcad.2017.12.002_bb0260","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ahj.2014.07.002","article-title":"Reasons for warfarin discontinuation in the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF)","volume":"168","author":"O'Brien","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.pcad.2017.12.002_bb0265","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1160\/TH16-12-0961","article-title":"Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients","volume":"117","author":"Rivera-Caravaca","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pcad.2017.12.002_bb0270","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1160\/TH16-11-0846","article-title":"Consequences of warfarin suspension after major bleeding in very elderly patients with non valvular atrial fibrillation","volume":"117","author":"Zoppellaro","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pcad.2017.12.002_bb0275","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1160\/TH15-04-0350","article-title":"Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study","volume":"115","author":"Martinez","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pcad.2017.12.002_bb0280","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/jama.2017.1371","article-title":"Association of preceding antithrombotic treatment with acute ischemic stroke severity and in-hospital outcomes among patients with atrial fibrillation","volume":"317","author":"Xian","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.pcad.2017.12.002_bb0285","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1160\/TH4-04-0383","article-title":"Adverse prognosis of incidentally detected ambulatory atrial fibrillation. A cohort study","volume":"112","author":"Martinez","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.pcad.2017.12.002_bb0290","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/jce.12864","article-title":"Targeted anticoagulation for atrial fibrillation guided by continuous rhythm assessment with an Insertable cardiac monitor: the rhythm evaluation for anticoagulation with continuous monitoring (REACT.COM) pilot study","volume":"27","author":"Passman","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.pcad.2017.12.002_bb0295","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.hrthm.2011.04.022","article-title":"Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS","volume":"8","author":"Daoud","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.pcad.2017.12.002_bb0300","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/CIRCULATIONAHA.113.007825","article-title":"Temporal relationship between subclinical atrial fibrillation and embolic events","volume":"129","author":"Brambatti","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.pcad.2017.12.002_bb0305","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1160\/TH12-03-0175","article-title":"The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0\u20131: a nationwide cohort study","volume":"107","author":"Olesen","year":"2012","journal-title":"Thromb Haemost"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062017301640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062017301640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T01:50:06Z","timestamp":1535161806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062017301640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":61,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0033062017301640"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2017.12.002","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantifying Time in Atrial Fibrillation and the Need for Anticoagulation","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2017.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}